tetano
Editor, Senior Moderator
J Infect Chemother
. 2023 Aug 31;S1341-321X(23)00202-7.
doi: 10.1016/j.jiac.2023.08.016. Online ahead of print. Association between rubella vaccination response and long-term immune response to severe acute respiratory syndrome coronavirus 2 after BNT162b2 vaccination
Kazuhiko Nakaharai[SUP] 1 [/SUP], Yasushi Nakazawa[SUP] 2 [/SUP], Masaki Yoshida[SUP] 3 [/SUP]
Affiliations
In a previous study, we demonstrated an association between a low response to rubella vaccination and a decreased acquisition of anti-severe acute respiratory syndrome coronavirus 2 spike immunoglobulin G (anti-S IgG) shortly after the second dose of the BNT162b2 vaccine. The present study aimed to explore whether this association persists in terms of long-term antibody retention following the second dose of BNT162b2. Through multivariable analysis, we found a significant association between a low response to rubella vaccination and reduced anti-S IgG titers approximately eight months after the second dose of BNT162b2.
Keywords: Antibody; BNT162b2; COVID-19; Rubella; SARS-CoV-2; Vaccine.
. 2023 Aug 31;S1341-321X(23)00202-7.
doi: 10.1016/j.jiac.2023.08.016. Online ahead of print. Association between rubella vaccination response and long-term immune response to severe acute respiratory syndrome coronavirus 2 after BNT162b2 vaccination
Kazuhiko Nakaharai[SUP] 1 [/SUP], Yasushi Nakazawa[SUP] 2 [/SUP], Masaki Yoshida[SUP] 3 [/SUP]
Affiliations
- PMID: 37659476
- DOI: 10.1016/j.jiac.2023.08.016
In a previous study, we demonstrated an association between a low response to rubella vaccination and a decreased acquisition of anti-severe acute respiratory syndrome coronavirus 2 spike immunoglobulin G (anti-S IgG) shortly after the second dose of the BNT162b2 vaccine. The present study aimed to explore whether this association persists in terms of long-term antibody retention following the second dose of BNT162b2. Through multivariable analysis, we found a significant association between a low response to rubella vaccination and reduced anti-S IgG titers approximately eight months after the second dose of BNT162b2.
Keywords: Antibody; BNT162b2; COVID-19; Rubella; SARS-CoV-2; Vaccine.